StockTipsArenaBeta

BUY Sai Life Sciences — Vikas Salunkhe, Nirmal Bang Securities

BUYSai Life Sciences
Sai Life Sciences share price target & all analyst calls

byVikas Salunkhe, Nirmal Bang SecuritiesHorizon: 1 year29 Oct 2026via Zee Business (Live)

Entry₹1,496.1Inferred
Target₹1,620
Total upside +8.28%
Stop loss₹1,400-6.42% risk
CMP₹1,557.55h ago
Active+4.10%+4.01%upside left 12 mo left
Follow Vikas Salunkhe for new callsGet alertsWatch SAILIFE for new buy/sell callsGet alertsSee 1 other Long-term call on SAILIFESee 410 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Oct, 9:22 pm IST
13 supporting2 neutral2 opposing
Supports the BUY call (13)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·30 Oct · today

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·29 Oct · yesterday

Sai Life Sciences Gets 'Buy' Rating As PL Capital Initiates Coverage; Check Target Price

NewsNdtv-Profit·22 Oct · 1w ago

(opens in new tab)

Buy Sai Life Sciences; target of Rs 1620: Prabhudas Lilladher

NewsGoogle News·21 Oct · 1w ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·21 Oct · 1w ago

Neutral / worth noting (2)

Q2 FY27 results scheduled — board meets 05 Nov 2026

BSE · Board Meeting·In 5 days

(opens in new tab)
Weighs against the BUY call (2)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sai Life Sciences

All analyst calls on Sai Life Sciences

More from Vikas Salunkhe, Nirmal Bang Securities

Every call and its outcome